Smith P, Arnesen H
Acta Med Scand. 1986;220(5):407-10. doi: 10.1111/j.0954-6820.1986.tb02788.x.
In order to assess the influence of warfarin on serum urate concentration, changes in serum urate were studied in 50 patients after myocardial infarction. The patients studied were part of a prospective, randomized placebo-controlled study of warfarin after myocardial infarction. Twenty-three of the patients were treated with warfarin and 27 received placebo. The mean uric acid level fell in both groups during an average of 10 months (range 6-20 months), the reduction being of the same order of magnitude in either group. This implies that warfarin, in contrast to some other oral anticoagulants, does not exert any uric acid lowering effect.
为了评估华法林对血清尿酸浓度的影响,我们对50例心肌梗死后患者的血清尿酸变化进行了研究。所研究的患者是心肌梗死后华法林前瞻性随机安慰剂对照研究的一部分。其中23例患者接受华法林治疗,27例接受安慰剂治疗。两组患者在平均10个月(范围6 - 20个月)期间血清尿酸水平均下降,两组下降幅度相当。这意味着与其他一些口服抗凝剂不同,华法林没有降低尿酸的作用。